clinical trials – Blog about neuroblastoma biology
Clinical trials evaluating ALK inhibitors in neuroblastoma. | Download Table
Summary of Pivotal Clinical Trials for RA use in Neuroblastoma. | Download Scientific Diagram
Doxorubicin for Newly Diagnosed High Risk Neuroblastoma Clinical Trial | Power
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma - European Journal
Grant Round 2021 — Neuroblastoma UK
Global Neuroblastoma Clinical Trial Pipeline Highlights - 2021
New Treatment for Neuroblastoma Is in Early-Stage Trials
Drugs of clinical trials for HR neuroblastoma interventetion | Download Table
Neuroblastoma Clinical Trials - CNCF
Clinical Trial Enrollment Fairly Robust in Pediatric Neuroblastoma - Physician's Weekly
Frontiers | CAR T Cell Therapy for Neuroblastoma | Immunology
Results of a prospective clinical trial JN‐L‐10 using image‐defined risk factors to inform surgical decisions for children with low‐risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee -
Current selected clinical trials on NB | Download Table
Too many targets, not enough patients: rethinking neuroblastoma clinical trials | Nature Reviews Cancer
Daily Dose - Neuroblastoma Clinical Trial Gives Two International Patients Another Chance at Life
SIOPEN High-Risk Neuroblastoma Clinical Trial 2 to open in the UK in 2021 — Neuroblastoma UK
Neuroblastoma Treatment and Clinical Trials
Integrative discovery of treatments for high-risk neuroblastoma | Nature Communications
Clinical trial for children with high-risk neuroblastoma open — Neuroblastoma UK
Targets and Antibody Formats for Immunotherapy of Neuroblastoma | Journal of Clinical Oncology
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma | Journal of Experimental & Clinical Cancer Research | Full Text
